POINT Biopharma Global Inc. (NASDAQ:PNT) Receives $12.88 Consensus Price Target from Analysts
POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report) has been given a consensus rating of “Hold” by the ten brokerages that are covering the stock, MarketBeat Ratings reports. Ten analysts have rated the stock with a hold recommendation. The average 1-year price objective among analysts that have issued a report on the stock in […]
More Stories
Meta Platforms, Inc. (NASDAQ:META) Shares Purchased by MainStreet Investment Advisors LLC
MainStreet Investment Advisors LLC boosted its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 2.1% during...
Meta Platforms, Inc. (NASDAQ:META) Shares Purchased by Heritage Wealth Management Inc. CA
Heritage Wealth Management Inc. CA boosted its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 32.6%...
China Universal Asset Management Co. Ltd. Grows Stake in JPMorgan Chase & Co. (NYSE:JPM)
China Universal Asset Management Co. Ltd. boosted its position in shares of JPMorgan Chase & Co. (NYSE:JPM) by 11.1% during...
Meta Platforms, Inc. (NASDAQ:META) Shares Sold by Alpine Woods Capital Investors LLC
Alpine Woods Capital Investors LLC decreased its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 16.8%...
Forthright Family Wealth Advisory LLC Sells 24 Shares of Meta Platforms, Inc. (NASDAQ:META)
Forthright Family Wealth Advisory LLC decreased its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 4.9%...
First Interstate Bank Acquires 4,435 Shares of Meta Platforms, Inc. (NASDAQ:META)
First Interstate Bank lifted its holdings in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 156.9% in the...